Skip to content

Clinical trials

Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Clear all

225 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20022
20033
20041
20051
20062
20073
20081
20096
20106
20114
20123
20133
20142
20158
20168
201713
201818
201918
202014
202115
202214
202320
202415
202522
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Recruiting56
Terminated40
Active, not recruiting26
Unknown status16
Withdrawn9
Not yet recruiting6
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)9
Dana-Farber Cancer Institute4
Genmab4
Washington University School of Medicine4
Incyte Biosciences International Sàrl3
M.D. Anderson Cancer Center3
University of Washington3
West China Hospital3
Alentis Therapeutics AG2
Amgen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck225
Carcinoma, Non-Small-Cell Lung74
Head and Neck Neoplasms56
Melanoma42
Triple Negative Breast Neoplasms35
Colorectal Neoplasms31
Carcinoma, Renal Cell30
Uterine Cervical Neoplasms29
Neoplasm Metastasis28
Stomach Neoplasms26

Trials

Showing 1 to 25 of 225. Each trial links to its page on Pharma Observatory.

125 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.